DGKZ
Basic information
Region (hg38): 11:46332905-46380554
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- atypical cerebral palsy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DGKZ gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 73 | 10 | 86 | |||
missense | 166 | 13 | 188 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 12 | 19 | 2 | 33 | ||
non coding | 42 | 12 | 56 | |||
Total | 1 | 0 | 176 | 129 | 31 |
Highest pathogenic variant AF is 0.000408
Variants in DGKZ
This is a list of pathogenic ClinVar variants found in the DGKZ region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-46333355-G-A | not specified | Uncertain significance (Oct 18, 2021) | ||
11-46333364-G-C | not specified | Uncertain significance (Oct 16, 2024) | ||
11-46333375-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
11-46333376-A-T | not specified | Uncertain significance (Dec 12, 2023) | ||
11-46333441-G-A | not specified | Uncertain significance (May 31, 2023) | ||
11-46333453-C-G | not specified | Uncertain significance (Feb 14, 2023) | ||
11-46333457-A-G | not specified | Uncertain significance (Aug 30, 2021) | ||
11-46347674-C-T | Likely benign (Dec 01, 2022) | |||
11-46347746-C-T | Likely benign (Nov 01, 2022) | |||
11-46366263-ACTTT-A | Uncertain significance (Jun 03, 2023) | |||
11-46366284-C-T | not specified | Uncertain significance (Feb 07, 2023) | ||
11-46366285-G-A | Benign (Nov 24, 2023) | |||
11-46366288-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
11-46366293-G-A | Uncertain significance (Dec 11, 2023) | |||
11-46366302-C-G | Benign (Jan 25, 2024) | |||
11-46366310-G-A | Likely benign (Jan 09, 2024) | |||
11-46366314-C-T | Uncertain significance (Feb 06, 2023) | |||
11-46366318-A-G | Benign (Jan 29, 2024) | |||
11-46366320-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
11-46366321-G-A | Uncertain significance (Jun 28, 2022) | |||
11-46366327-G-A | not specified | Uncertain significance (Dec 05, 2024) | ||
11-46366333-T-C | Benign (Jan 22, 2024) | |||
11-46366356-C-T | Likely benign (May 17, 2023) | |||
11-46366357-G-A | not specified | Uncertain significance (Aug 04, 2023) | ||
11-46366359-C-A | not specified | Uncertain significance (Dec 15, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DGKZ | protein_coding | protein_coding | ENST00000454345 | 31 | 47650 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0395 | 0.960 | 125698 | 1 | 23 | 125722 | 0.0000955 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.76 | 493 | 698 | 0.706 | 0.0000460 | 7089 |
Missense in Polyphen | 120 | 276.48 | 0.43403 | 2913 | ||
Synonymous | -0.0469 | 288 | 287 | 1.00 | 0.0000192 | 2261 |
Loss of Function | 5.73 | 17 | 68.0 | 0.250 | 0.00000404 | 679 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000186 | 0.000182 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000282 | 0.000231 |
European (Non-Finnish) | 0.0000940 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000103 | 0.0000980 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Displays a strong preference for 1,2-diacylglycerols over 1,3-diacylglycerols, but lacks substrate specificity among molecular species of long chain diacylglycerols. Isoform 2 but not isoform 1 regulates RASGRP1 activity (PubMed:11257115). Positively regulates insulin-induced translocation of SLC2A4 to the cell membrane in adipocytes (By similarity). Activates PIP5K1A activity via generation of phosphatidic acid (PubMed:15157668). {ECO:0000250|UniProtKB:Q80UP3, ECO:0000269|PubMed:11257115, ECO:0000269|PubMed:15157668}.;
- Pathway
- Glycerolipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Phosphatidylinositol signaling system - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Myometrial Relaxation and Contraction Pathways;Leptin Insulin Overlap;Signaling by GPCR;Signal Transduction;Effects of PIP2 hydrolysis;Platelet activation, signaling and aggregation;Glycerophospholipid metabolism;Hemostasis;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.238
Intolerance Scores
- loftool
- 0.606
- rvis_EVS
- 0.27
- rvis_percentile_EVS
- 70.69
Haploinsufficiency Scores
- pHI
- 0.130
- hipred
- Y
- hipred_score
- 0.790
- ghis
- 0.464
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dgkz
- Phenotype
- immune system phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- phosphatidic acid biosynthetic process;protein kinase C-activating G protein-coupled receptor signaling pathway;cell migration;platelet activation;intracellular signal transduction;diacylglycerol metabolic process;glycerolipid metabolic process;lipid phosphorylation;positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity
- Cellular component
- nucleus;cytoplasm;plasma membrane;postsynaptic density;nuclear speck;lamellipodium;glutamatergic synapse
- Molecular function
- NAD+ kinase activity;diacylglycerol kinase activity;protein binding;ATP binding;kinase activity;metal ion binding